The genetic association between the SLC30A8 gene and the increased risk of T2DM and diabetic nephropathy (DN) was investigated, by examining the DNA methylation status of six CpG sites in the SLC30A8 promoter using blood samples. This evidence concerns the gene SLC30A8 and liver dysplastic nodule.